Statistical validation of surrogate outcome measures

Por Buyse, Marc
Publicado em 2011

Data fraud in clinical trials

Por George, Stephen L, Buyse, Marc
Publicado no Clin Investig (Lond) (2015)

The evaluation of surrogate endpoints

Por Burzykowski, Tomasz., Molenberghs, Geert., Buyse, Marc.
Publicado em 2005

Common pitfalls in statistical analysis: “No evidence of effect” versus “evidence of no effect”

Por Ranganathan, Priya, Pramesh, C. S., Buyse, Marc
Publicado no Perspect Clin Res (2015)

Common pitfalls in statistical analysis: “P” values, statistical significance and confidence intervals

Por Ranganathan, Priya, Pramesh, C. S., Buyse, Marc
Publicado no Perspect Clin Res (2015)

Common pitfalls in statistical analysis: Clinical versus statistical significance

Por Ranganathan, Priya, Pramesh, C. S., Buyse, Marc
Publicado no Perspect Clin Res (2015)

Common pitfalls in statistical analysis: The perils of multiple testing

Por Ranganathan, Priya, Pramesh, C. S., Buyse, Marc
Publicado no Perspect Clin Res (2016)

Predicting treatment effect from surrogate endpoints and historical trials: an extrapolation involving probabilities of a binary outcome or survival to a specific time

Por Baker, Stuart G., Sargent, Daniel J., Buyse, Marc, Burzykowski, Tomasz
Publicado em 2011

The ARCAD Clinical Trials Program: An Update and Invitation

Por Sargent, Daniel J., Buyse, Marc, Matheson, Alastair, Goldberg, Richard M., de Gramont, Aimery
Publicado em 2012

Assessment of the consistency and robustness of results from a multicenter trial of remission maintenance therapy for acute myeloid leukemia

Por Buyse, Marc, Squifflet, Pierre, Lucchesi, Kathryn J, Brune, Mats L, Castaigne, Sylvie, Rowe, Jacob M
Publicado em 2011

Comparison of treatment effect sizes associated with surrogate and final patient relevant outcomes in randomised controlled trials: meta-epidemiological study

Por Ciani, Oriana, Buyse, Marc, Garside, Ruth, Pavey, Toby, Stein, Ken, Sterne, Jonathan A C, Taylor, Rod S
Publicado em 2013

Leukemia-free survival as a surrogate end point for overall survival in the evaluation of maintenance therapy for patients with acute myeloid leukemia in complete remission

Por Buyse, Marc, Michiels, Stefan, Squifflet, Pierre, Lucchesi, Kathryn J., Hellstrand, Kristoffer, Brune, Mats L., Castaigne, Sylvie, Rowe, Jacob M.
Publicado em 2011

Comparison of prognostic gene expression signatures for breast cancer

Por van't Veer Laura, Cardoso Fatima, Buyse Marc, Piette Fanny, Desmedt Christine, Haibe-Kains Benjamin, Piccart Martine, Bontempi Gianluca, Sotiriou Christos
Publicado em 2008-08-01

Comparison of prognostic gene expression signatures for breast cancer

Por Haibe-Kains, Benjamin, Desmedt, Christine, Piette, Fanny, Buyse, Marc, Cardoso, Fatima, van't Veer, Laura, Piccart, Martine, Bontempi, Gianluca, Sotiriou, Christos
Publicado em 2008

An assessment of the benefit-risk balance of FOLFIRINOX in metastatic pancreatic adenocarcinoma

Por Péron, Julien, Roy, Pascal, Conroy, Thierry, Desseigne, Françoise, Ychou, Marc, Gourgou-Bourgade, Sophie, Stanbury, Trevor, Roche, Laurent, Ozenne, Brice, Buyse, Marc
Publicado no Oncotarget (2016)

Prediction of survival benefits from progression-free survival benefits in advanced non-small-cell lung cancer: evidence from a meta-analysis of 2334 patients from 5 randomised tri...

Por Laporte, Silvy, Squifflet, Pierre, Baroux, Noémie, Fossella, Frank, Georgoulias, Vassilis, Pujol, Jean-Louis, Douillard, Jean-Yves, Kudoh, Shinzohy, Pignon, Jean-Pierre, Quinaux, Emmanuel, Buyse, Marc
Publicado em 2013

Individual patient data meta-analysis of randomized trials evaluating IL-2 monotherapy as remission maintenance therapy in acute myeloid leukemia

Por Buyse, Marc, Squifflet, Pierre, Lange, Beverly J., Alonzo, Todd A., Larson, Richard A., Kolitz, Jonathan E., George, Stephen L., Bloomfield, Clara D., Castaigne, Sylvie, Chevret, Sylvie, Blaise, Didier, Maraninchi, Dominique, Lucchesi, Kathryn J., Burzykowski, Tomasz
Publicado em 2011

Evidence for Cure by Adjuvant Therapy in Colon Cancer: Observations Based on Individual Patient Data From 20,898 Patients on 18 Randomized Trials

Por Sargent, Daniel, Sobrero, Alberto, Grothey, Axel, O'Connell, Michael J., Buyse, Marc, Andre, Thierry, Zheng, Yan, Green, Erin, Labianca, Roberto, O'Callaghan, Chris, Seitz, Jean Francois, Francini, Guido, Haller, Daniel, Yothers, Greg, Goldberg, Richard, de Gramont, Aimery
Publicado em 2009

Circulating Tumor Cell Biomarker Panel As an Individual-Level Surrogate for Survival in Metastatic Castration-Resistant Prostate Cancer

Por Scher, Howard I., Heller, Glenn, Molina, Arturo, Attard, Gerhardt, Danila, Daniel C., Jia, Xiaoyu, Peng, Weimin, Sandhu, Shahneen K., Olmos, David, Riisnaes, Ruth, McCormack, Robert, Burzykowski, Tomasz, Kheoh, Thian, Fleisher, Martin, Buyse, Marc, de Bono, Johann S.
Publicado no J Clin Oncol (2015)

Association Between Disease-Free Survival and Overall Survival When Survival Is Prolonged After Recurrence in Patients Receiving Cytotoxic Adjuvant Therapy for Colon Cancer: Simula...

Por de Gramont, Aimery, Hubbard, Joleen, Shi, Qian, O'Connell, Michael J., Buyse, Marc, Benedetti, Jacqueline, Bot, Brian, O'Callaghan, Chris, Yothers, Greg, Goldberg, Richard M., Blanke, Charles D., Benson, Al, Deng, Qiqi, Alberts, Steven R., Andre, Thierry, Wolmark, Norman, Grothey, Axel, Sargent, Daniel
Publicado em 2010